MARCH 18, 2020 – VICTORIA, British Columbia –(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications,… Read More
Updated March 19, 2020 – The global outbreak of the novel coronavirus (COVID-19) is an issue of growing concern around the world. The innovative pharmaceutical industry is working around the… Read More
Ottawa, March 18, 2020—As Canada responds to the global COVID-19 pandemic, some Canadians have expressed concern that they may not have access to the medicines they need, when they need… Read More
This year marks the 20th anniversary of the province’s flagship startup competition VANCOUVER, B.C. – The 2020 New Ventures Competition, presented by Innovate BC, is officially underway. Applications are now… Read More
AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create antibody therapeutics for treatment and prevention of… Read More
